Economy

How Many Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)'s Analysts Are Bullish?

How Many Ultragenyx Pharmaceutical Inc (NASDAQ:RARE)'s Analysts Are Bullish?”

The last stock price is up -22.84% from the 200-day moving average, compared to the S&P 500 which has increased 0.04% over the same period. Zacks Investment Research lowered shares of Ultragenyx Pharmaceutical from a hold rating to a sell rating in a research note on Tuesday, July 11th. Monarch Partners Asset Management Llc acquired 381,654 shares as Exar Corp (EXAR)'s stock 0.00%. It is 0.00% or $0 reaching $12.99 per share.

About 128,656 shares traded. It is down 0.00% since September 10, 2016 and is.

Ultragenyx Pharmaceutical (NASDAQ:RARE) last issued its quarterly earnings data on Thursday, July 27th. Stifel Nicolaus restated a buy rating and issued a $85.00 price objective (down previously from $95.00) on shares of Ultragenyx Pharmaceutical in a report on Wednesday, August 23rd. The company has market cap of $2.14 billion. The stock decreased 0.08% or $0.04 on September 8, reaching $49.96.

Investors are more bullish on Ultragenyx Pharmaceutical Inc.as evidenced by the fall in short interest. It has underperformed by 36.98% the S&P500.

Investors sentiment increased to 1.16 in Q4 2016. Its up 0.75, from 1.09 in 2016Q3. Finally, Capital International Investors boosted its holdings in Ultragenyx Pharmaceutical by 9.1% during the 2nd quarter. Advisory holds 4.55% or 8.54M shares. Beese Fulmer Management accumulated 155,056 shares. North Corp has invested 1.32% in AT&T Inc. Opus Point Management Ltd Llc has 10,864 shares for 0.61% of their portfolio. (NYSE:T) for 11.17M shares. (NYSE:T). Ariel Capital Advisors Lc stated it has 0.29% of its portfolio in AT&T Inc. Metropolitan Life New York reported 25,174 shares. 49,387 were reported by Nationwide Fund Advsrs. Jupiter Asset Management Limited invested in 219,248 shares. (OMC), Ultragenyx Pharmaceutical Inc (RARE) and Stryker ..." published on August 23, 2017 as well as Seekingalpha.com's news article titled: "Ultragenyx: "Short Opportunity" with publication date: "August 23, 2017. BlackRock Inc. now owns 3,973 shares of the biopharmaceutical company's stock valued at $194,000 after buying an additional 1,467 shares in the last quarter.

Among 25 analysts covering AT&T Inc. The one year target is $96.40 with zero equity analysts rating the stock a strong buy, 0 brokers rating the stock a buy, 0 firms rating the stock a hold, 0 brokerages rating the company a underperform, and lastly zero brokerages rating the company a sell.

Ratings analysis reveals 55% of Ultragenyx Pharmaceutical Inc's analysts are positive. The stock of AT&T Inc. "(NASDAQ:RARE) Stock Rating Reaffirmed by Stifel Nicolaus" was originally posted by Week Herald and is the sole property of of Week Herald. The company was maintained on Wednesday, August 5 by Cowen & Co. Jefferies has "Hold" rating and $62.0 target. The firm has "Buy" rating by Argus Research given on Tuesday, April 11.

Investors sentiment decreased to 0.07 in Q4 2016. Its down 1.95, from 1.95 in 2016Q3. Sold All: 17 Reduced: 56 Increased: 54 New Position: 24. 58 funds opened positions while 108 raised stakes.

California State Teachers Retirement System increased its stake in Ultragenyx Pharmaceutical Inc. On average, equities research analysts forecast that Ultragenyx Pharmaceutical will post ($7.21) EPS for the current year. Morgan Stanley has 136,060 shares for 0% of their portfolio. Dekabank Deutsche Girozentrale holds 0.02% of its portfolio in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) for 27,820 shares. Point72 Asset Management, L.p. downsized its ownership by selling 15,000 shares a decrease of 18.8% as of 06/30/2017. Gam Holding Ag holds 66,400 shares. Laurion Capital LP reported 2,900 shares stake. Prudential Financial Inc. raised its position in shares of Ultragenyx Pharmaceutical by 5.8% during the 1st quarter. Smith Asset Mgmt Gru Lp has invested 0.02% in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE). Bank & Trust Of America De reported 44,460 shares stake. Jefferies Group LLC restated a hold rating and set a $68.00 price objective on shares of Ultragenyx Pharmaceutical in a report on Friday, July 14th. Therefore 55% are positive. Moreover, Tiaa Cref Investment Management Ltd Limited Liability Company has 0.01% invested in Ultragenyx Pharmaceutical Inc (NASDAQ:RARE). As per Tuesday, June 28, the company rating was initiated by Bank of America. Finally, BidaskClub downgraded Ultragenyx Pharmaceutical from a "buy" rating to a "hold" rating in a research report on Tuesday, August 1st. The stock of Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) has "Buy" rating given on Tuesday, August 22 by Robert W. Baird. August 23 investment analysts at JMP Securities made no change to the stock rating of "Market Outperform" but lowered the price target to $80.00 from $84.00. The rating was upgraded by Goldman Sachs on Monday, May 23 to "Buy". The rating was initiated by Raymond James with "Outperform" on Tuesday, September 1. The stock of Ultragenyx Pharmaceutical Inc (NASDAQ:RARE) has "Outperform" rating given on Friday, February 19 by Leerink Swann. Boston Prtnrs holds 1.70 million shares or 0.02% of its portfolio.



Like this

Latest


12 September 2017
$-0.01 EPS Expected for BlackBerry Ltd (BB)
If you are accessing this report on another publication, it was stolen and reposted in violation of US & global copyright laws. Cetera Investment Advisers acquired a new position in BlackBerry Limited in the 2nd quarter valued at about $279,000.

12 September 2017
Southern Copper Corporation (NYSE:SCCO) Shares Bought by Andra AP fonden
It improved, as 59 investors sold Fiserv Inc shares while 308 reduced holdings. 77 funds opened positions while 290 raised stakes. More interesting news about Dominion Energy Inc (NYSE:D) was released by: Nasdaq.com and their article: "Dominion Energy, Inc".

12 September 2017
People campaigning for Kalsoom Nawaz in NA-120 election: Maryam
The PML-N stalwart said that he can not accept Maryam as a political leader as lot of struggle is required to be a leader. The workers' convention is held in connection with the campaign for NA-120 by-election that is due on September 17.

12 September 2017
Putin says no war to happen on Korean Peninsula
Putin said that North Korea won't agree to end its nuclear program in return for easing sanctions. But, the blast was clearly North Korea's strongest.

12 September 2017
California challenges President Trump's end to young immigrant programme DACA
President Trump said he would end the DACA program if Congress hasn't acted within six months to enact it into law. In July, Becerra was among the attorneys general who wrote to Trump, urging him to retain the DACA program.

12 September 2017
Hurricanes Irma and Jose as seen from the International Space Station
Although 2017 may not set a new standard, NOAA had warned that this season had the "potential to be extremely active". Hurricane Katia is the third to form in the Atlantic region behind Irma (left) and Jose (right).

12 September 2017
Katie Taylor will challenge for world title next month
Her most recent victory came at the end of July, when she stopped the over-matched Jasmine Clarkson at the Barclays Center in Brooklyn.

12 September 2017
Patriots replacing Gillette Stadium turf after installing it in May
The Patriots played two preseason games and one regular season game on the turf since it was installed in May. New England lost its regular season home opener to the Kansas City Chiefs this past Thursday night, 42-27.

12 September 2017
Analysts Watch Kimberly-Clark Corporation (NYSE:KMB) And Issue New Targets
Currently, 444.09 million total shares are owned by the public and among those 435.74 million shares have been available to trade. Kimberly-Clark Corporation ( KMB ) has an Analysts' Mean Recommendation of 2.9, according to data compiled by Finviz.

12 September 2017
Scotiabank Cuts Continental Resources, Inc. (CLR) Price Target to $13.50
Among 33 analysts covering Continental Resources Inc. (NYSE:CLR) has risen 4.05% since September 11, 2016 and is uptrending. State Of Tennessee Treasury Department reported 240,000 shares. (NYSE:CLR), 20 have Buy rating, 0 Sell and 13 Hold.



Recommended